Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean McBride

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Musculoskeletal Science & Practice|February 22, 2026
International normative values for the weight-bearing lunge test across age and sex in 899 healthy adultsSean McBride, Pier-Luc Isabelle, Álvaro Gómez-Carrión, et al.
Head & Neck|September 4, 2015
Postoperative PET/CT and target delineation before adjuvant radiotherapy in patients with oral cavity squamous cell carcinomaPinaki R Dutta, Nadeem Riaz, Sean McBride, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|April 22, 2011
Wetting morphologies and their transitions in grooved substratesRalf Seemann, Martin Brinkmann, Stephan Herminghaus, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2020
Low-Dose-Rate Brachytherapy Combined With Ultrahypofractionated Radiation Therapy for Clinically Localized, Intermediate-Risk Prostate Cancer: Results From a Prospective TrialMarisa A Kollmeier, Sean McBride, Melissa Varghese, et al.
Brachytherapy|September 30, 2021
Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancerDaniel Gorovets, Margaret Hopkins, Marisa Kollmeier, et al.
BJU International|May 3, 2017
Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancerZachary S Zumsteg, Michael J Zelefsky, Kaitlin M Woo, et al.
European Urology|October 14, 2014
The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapyZachary S Zumsteg, Daniel E Spratt, Paul B Romesser, et al.
Brachytherapy|August 26, 2017
Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling timeMarisa A Kollmeier, Sean McBride, Amandeep Taggar, et al.
Tissue Engineering. Part A|January 7, 2012
Bone regeneration in a rabbit critical-sized calvarial model using tyrosine-derived polycarbonate scaffoldsJinku Kim, Maria Hanshella R Magno, Heather Waters, et al.
European Urology Oncology|November 1, 2019
Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate CancerMichael J Zelefsky, Attapol Pinitpatcharalert, Marisa Kollmeier, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Musculoskeletal Science & Practice|February 22, 2026
International normative values for the weight-bearing lunge test across age and sex in 899 healthy adultsSean McBride, Pier-Luc Isabelle, Álvaro Gómez-Carrión, et al.
Head & Neck|September 4, 2015
Postoperative PET/CT and target delineation before adjuvant radiotherapy in patients with oral cavity squamous cell carcinomaPinaki R Dutta, Nadeem Riaz, Sean McBride, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|April 22, 2011
Wetting morphologies and their transitions in grooved substratesRalf Seemann, Martin Brinkmann, Stephan Herminghaus, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2020
Low-Dose-Rate Brachytherapy Combined With Ultrahypofractionated Radiation Therapy for Clinically Localized, Intermediate-Risk Prostate Cancer: Results From a Prospective TrialMarisa A Kollmeier, Sean McBride, Melissa Varghese, et al.
Brachytherapy|September 30, 2021
Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancerDaniel Gorovets, Margaret Hopkins, Marisa Kollmeier, et al.
BJU International|May 3, 2017
Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancerZachary S Zumsteg, Michael J Zelefsky, Kaitlin M Woo, et al.
European Urology|October 14, 2014
The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapyZachary S Zumsteg, Daniel E Spratt, Paul B Romesser, et al.
Brachytherapy|August 26, 2017
Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling timeMarisa A Kollmeier, Sean McBride, Amandeep Taggar, et al.
Tissue Engineering. Part A|January 7, 2012
Bone regeneration in a rabbit critical-sized calvarial model using tyrosine-derived polycarbonate scaffoldsJinku Kim, Maria Hanshella R Magno, Heather Waters, et al.
European Urology Oncology|November 1, 2019
Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate CancerMichael J Zelefsky, Attapol Pinitpatcharalert, Marisa Kollmeier, et al.
Pageof 10